Muriel Bardet
Director of Finance/CFO bij THERADIAG
Profiel
Muriel Bardet is currently the Finance Director at DNA Script SAS and also holds the position of Chief Financial Officer at Theradiag SA. Prior to her current roles, she worked at Sanofi as Director-Finance for Asia Pacific & Latin America and at Chugai Sanofi-aventis SNC as Financial Director.
She also worked as a Finance Controller at Bristol-Myers Squibb SARL.
Bardet received her undergraduate degree from Audencia and her graduate degree from Sorbonne Université.
Actieve functies van Muriel Bardet
| Bedrijven | Functie | Begin |
|---|---|---|
| THERADIAG | Director of Finance/CFO | - |
DNA Script SAS
 DNA Script SAS Medical SpecialtiesHealth Technology DNA Script engages in the provision of research and development in biotechnology. It manufactures synthetic deoxyribonucleic acid using enzymatic technology. The company was founded by Thomas Ybert, Sylvain Gariel and Xavier Godron in 2014 and is headquartered in Paris, France. | Director of Finance/CFO | 01-12-2019 |
Eerdere bekende functies van Muriel Bardet
| Bedrijven | Functie | Einde |
|---|---|---|
Chugai Sanofi-aventis SNC
 Chugai Sanofi-aventis SNC Pharmaceuticals: MajorHealth Technology Part of Roche Holding AG, Chugai Sanofi-aventis SNC is a French pharmaceutical company that manufactures and distributes pharmaceuticals. The private company is based in Anthony, France. | Director of Finance/CFO | 01-12-2016 |
| SANOFI | Comptroller/Controller/Auditor | - |
Bristol-Myers Squibb SARL
 Bristol-Myers Squibb SARL Medical DistributorsDistribution Services Bristol-Myers Squibb SARL engages in the research, development, manufacture, and distribution of pharmaceutical products. Its therapeutic areas include immunoscience, immune-oncology, and cardiology. The company is headquartered in Rueil-Malmaison, France. | Comptroller/Controller/Auditor | 01-05-2000 |
Opleiding van Muriel Bardet
| Audencia | Undergraduate Degree |
| Sorbonne Université | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| SANOFI | Health Technology |
| Bedrijven in privébezit | 4 |
|---|---|
Theradiag SA
 Theradiag SA Medical SpecialtiesHealth Technology Theradiag SA engages in the distribution, development, and manufacturing of in vitro diagnostic and theranostics tests. It operates through the following segments: Theranostics and Diagnostics. The Theranostics segment offers solutions for patients treated with anti-tumour necrosis factor alpha. The Diagnostics segment includes products for anti-immunity, genetics, allergy, infectious disease, drug of abuse, other diagnoses, and instrumentation. The company was founded on December 29, 1986 and is headquartered in Croissy-Beaubourg, France. | Health Technology |
Bristol-Myers Squibb SARL
Bristol-Myers Squibb SARL Medical DistributorsDistribution Services Bristol-Myers Squibb SARL engages in the research, development, manufacture, and distribution of pharmaceutical products. Its therapeutic areas include immunoscience, immune-oncology, and cardiology. The company is headquartered in Rueil-Malmaison, France. | Distribution Services |
Chugai Sanofi-aventis SNC
Chugai Sanofi-aventis SNC Pharmaceuticals: MajorHealth Technology Part of Roche Holding AG, Chugai Sanofi-aventis SNC is a French pharmaceutical company that manufactures and distributes pharmaceuticals. The private company is based in Anthony, France. | Health Technology |
DNA Script SAS
DNA Script SAS Medical SpecialtiesHealth Technology DNA Script engages in the provision of research and development in biotechnology. It manufactures synthetic deoxyribonucleic acid using enzymatic technology. The company was founded by Thomas Ybert, Sylvain Gariel and Xavier Godron in 2014 and is headquartered in Paris, France. | Health Technology |
